Clinical Trials Browser

Phase 2 × Immunotherapy × Capecitabine × Clear all

NCT05479240 2023-06-18

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

Immunotherapy